CVS Health
CVS
1,683 hedge funds and large institutions have $63.9B invested in CVS Health in 2019 Q3 according to their latest regulatory filings, with 137 funds opening new positions, 773 increasing their positions, 626 reducing their positions, and 95 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 48 → 84 (+36)
44% more first-time investments, than exits
New positions opened: 137 | Existing positions closed: 95
23% more repeat investments, than reductions
Existing positions increased: 773 | Existing positions reduced: 626
17% more capital invested
Capital invested by funds: $54.6B → $63.9B (+$9.22B)
11% more call options, than puts
Call options by funds: $1.5B | Put options by funds: $1.35B
2% more funds holding
Funds holding: 1,654 → 1,683 (+29)
0.64% more ownership
Funds ownership: 77.31% → 77.95% (+0.64%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$400M |
| 2 |
BlackRock
New York
|
+$187M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$154M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$142M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$101M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$328M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$169M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$158M |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$137M |
| 5 |
D.E. Shaw & Co
New York
|
-$135M |
CVS Hedge Fund Activity: Q3 2019 in Review
1,683 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2019, worth a combined $63.9B — up 17% from $54.6B a quarter earlier.
Buyers outnumbered sellers: 137 funds opened new CVS positions and 95 closed out — a net gain of 42 holders — while 773 added to existing stakes and 626 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $400M. The largest seller was Veritas Asset Management, cutting an estimated $328M.
- 1,683 institutional investors held CVS Health (CVS) as of Q3 2019, up from 1,654 in Q2 2019.
- Funds reported $63.9B of CVS Health stock for Q3 2019, up 17% quarter-over-quarter.
- 137 funds opened new CVS Health positions in Q3 2019 and 95 closed out, a net change of +42 holders.
- The largest CVS Health buyer in Q3 2019 was Wellington Management Group, an estimated $400M added.
- The largest CVS Health seller in Q3 2019 was Veritas Asset Management, an estimated $328M sold.
Based on aggregated 13F filings for Q3 2019.